Changbin Qiu
Actelion (Switzerland)(CH)
Publications by Year
Research Areas
Nitric Oxide and Endothelin Effects, Renin-Angiotensin System Studies, Blood Pressure and Hypertension Studies, Eicosanoids and Hypertension Pharmacology, Hormonal Regulation and Hypertension
Most-Cited Works
- → Promotion of sleep by targeting the orexin system in rats, dogs and humans(2007)566 cited
- → Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist(2008)324 cited
- → Pharmacology of the Urotensin-II Receptor Antagonist Palosuran (ACT-058362; 1-[2-(4-Benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea Sulfate Salt): First Demonstration of a Pathophysiological Role of the Urotensin System(2004)132 cited
- → Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production(1995)129 cited
- → Importance of nitric oxide in the control of renal hemodynamics(1996)125 cited
- Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats.(2006)
- → Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome.(1992)92 cited
- → The Urotensin-II Receptor Antagonist Palosuran Improves Pancreatic and Renal Function in Diabetic Rats(2006)90 cited
- → Evolution of Chronic Nitric Oxide Inhibition Hypertension(1998)74 cited
- → Chronic Endothelin Receptor Blockade Prevents Both Early Hyperfiltration and Late Overt Diabetic Nephropathy in the Rat(2003)63 cited